Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Change in Inventory: 2023-2024

Historic Change in Inventory for Seres Therapeutics (MCRB) over the last 2 years, with Dec 2024 value amounting to $33.8 million.

  • Seres Therapeutics' Change in Inventory fell 20.78% to $10.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $44.9 million, marking a year-over-year change of. This contributed to the annual value of $33.8 million for FY2024, which is 13.99% up from last year.
  • Per Seres Therapeutics' latest filing, its Change in Inventory stood at $33.8 million for FY2024, which was up 13.99% from $29.6 million recorded in FY2023.
  • Seres Therapeutics' 5-year Change in Inventory high stood at $33.8 million for FY2024, and its period low was $29.6 million during FY2023.
  • In the last 2 years, Seres Therapeutics' Change in Inventory had a median value of $31.7 million in 2023 and averaged $31.7 million.
  • Data for Seres Therapeutics' Change in Inventory shows a peak YoY rose of 13.99% (in 2024) over the last 5 years.
  • Seres Therapeutics' Change in Inventory (Yearly) stood at $29.6 million in 2023, then increased by 13.99% to $33.8 million in 2024.